Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Modafinil products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A wakefulness-promoting medicine used to treat excessive sleepiness, such as in narcolepsy.
Products affected
1 / 6
In shortage since
Apr 1, 2017
Reports on file
16
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
BIO-MODAFINIL
100MG · TABLET · BIOMED PHARMA
DIN 02442078 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Resolved
TEVA-MODAFINIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02420260 · ended Jun 24, 2026 · Disruption of the manufacture of the drug.
Discontinued
ALERTEC
100MG · TABLET · TEVA CANADA LIMITED
DIN 02239665
Discontinued
TEVA-MODAFINIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02420260
Resolved
APO-MODAFINIL
100MG · TABLET · APOTEX INC
DIN 02285398 · ended Apr 3, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-MODAFINIL
100MG · TABLET · APOTEX INC
DIN 02285398 · ended Dec 12, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-MODAFINIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02420260 · ended Nov 27, 2024 · Disruption of the manufacture of the drug.
Resolved
AURO-MODAFINIL
100MG · TABLET · AURO PHARMA INC
DIN 02430487 · ended Sep 13, 2024 · Demand increase for the drug.
Resolved
APO-MODAFINIL
100MG · TABLET · APOTEX INC
DIN 02285398 · ended Oct 26, 2023 · Disruption of the manufacture of the drug.
Resolved
ALERTEC
100MG · TABLET · TEVA CANADA LIMITED
DIN 02239665 · ended Sep 22, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-MODAFINIL
100MG · TABLET · APOTEX INC
DIN 02285398 · ended Feb 18, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-MODAFINIL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02420260 · ended May 13, 2020 · Disruption of the manufacture of the drug.
Showing 12 of 16 reports. All reports are on file with Health Canada.
What's happening
Modafinil is currently affected by an active shortage report filed with Health Canada by BIOMED PHARMA.
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Modafinil is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).
Recent changes
No changes recorded yet.
Common questions
What is Modafinil used for?
A wakefulness-promoting medicine used to treat excessive sleepiness, such as in narcolepsy.
When will Modafinil be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Modafinil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.